Cg Oncology Inc [CGON] stock is trading at $39.41, up 1.47%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CGON shares have gain 3.82% over the last week, with a monthly amount drifted -8.03%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on October 08, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $90. Previously, Piper Sandler started tracking the stock with Overweight rating on August 19, 2025, and set its price target to $55. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $41 on May 02, 2025. Scotiabank initiated its recommendation with a Sector Perform and recommended $23 as its price target on April 16, 2025. In a note dated October 24, 2024, UBS initiated an Buy rating and provided a target price of $60 on this stock.
Cg Oncology Inc [CGON] stock has fluctuated between $14.80 and $45.56 over the past year. Currently, Wall Street analysts expect the stock to reach $74.67 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $39.41 at the most recent close of the market. An investor can expect a potential return of 89.47% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Cg Oncology Inc [NASDAQ:CGON] reported sales of 0.55M for the trailing twelve months, which represents a drop of -100.00%. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at -285.46%, Pretax Profit Margin comes in at -232.45%, and Net Profit Margin reading is -157.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.13 and Total Capital is -0.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 38.24 points at the first support level, and at 37.08 for the second support level. However, for the 1st resistance point, the stock is sitting at 40.26, and for the 2nd resistance point, it is at 41.12.
Ratios To Look Out For
For context, Cg Oncology Inc’s Current Ratio is 22.15. In addition, the Quick Ratio stands at 22.15 and the Cash Ratio stands at 0.48. Considering the valuation of this stock, the price to sales ratio is 5463.49, the price to book ratio is 4.48.
Transactions by insiders
Recent insider trading involved POST LEONARD E, Director, that happened on Oct 13 ’25 when 1000.0 shares were sold. Director, Mulay James completed a deal on Oct 09 ’25 to sell 5903.0 shares. Meanwhile, Director JAMES MULAY bought 6557.0 shares on Oct 09 ’25.
